Icon Plc $ICLR Shares Bought by Stephens Investment Management Group LLC

Stephens Investment Management Group LLC raised its stake in Icon Plc (NASDAQ:ICLR – Free Report) by 10.3% during the 1st quarter, HoldingsChannel reports. The firm owned 599,176 shares of the medical research company’s stock after acquiring an additional 56,180 shares during the period. Stephens Investment Management Group LLC’s holdings in Icon were worth $66,305,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the stock. Toth Financial Advisory Corp acquired a new stake in shares of Icon during the fourth quarter worth $27,000. EFG International AG purchased a new position in Icon in the 4th quarter valued at $27,000. Ameriflex Group Inc. acquired a new position in Icon in the 3rd quarter valued at $33,000. Abound Financial LLC purchased a new position in Icon during the 4th quarter worth $54,000. Finally, Johnson Financial Group Inc. purchased a new position in Icon during the 3rd quarter worth $71,000. Institutional investors and hedge funds own 95.61% of the company’s stock.

Get Icon alerts:

Icon Price Performance

ICLR stock opened at $173.06 on Friday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.14 and a quick ratio of 1.14. The company’s 50 day simple moving average is $135.33 and its 200-day simple moving average is $137.87. Icon Plc has a 12 month low of $66.57 and a 12 month high of $211.00. The firm has a market capitalization of $13.25 billion, a PE ratio of 30.79, a P/E/G ratio of 8.49 and a beta of 1.22.

Icon (NASDAQ:ICLR – Get Free Report) last posted its earnings results on Tuesday, June 23rd. The medical research company reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.43 by $0.07. Icon had a return on equity of 8.73% and a net margin of 5.35%.The firm had revenue of $2.03 billion for the quarter, compared to analyst estimates of $1.98 billion. During the same quarter in the prior year, the company earned $3.43 EPS. Icon’s revenue was up 2.5% on a year-over-year basis. Equities analysts expect that Icon Plc will post 9.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on ICLR. TD Cowen lifted their target price on shares of Icon from $164.00 to $197.00 and gave the company a “buy” rating in a report on Thursday, June 25th. Bank of America increased their price target on shares of Icon from $125.00 to $150.00 and gave the stock an “underperform” rating in a report on Thursday, June 25th. Truist Financial upgraded shares of Icon from a “hold” rating to a “buy” rating and raised their price objective for the company from $159.00 to $207.00 in a research report on Tuesday. Citigroup raised their price objective on shares of Icon from $140.00 to $165.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. Finally, Piper Sandler cut Icon to a “neutral” rating in a research report on Thursday, May 28th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $173.19.

Read Our Latest Analysis on ICLR

Icon Company Profile

(Free Report)

Icon plc (NASDAQ: ICLR) is a global provider of outsourced drug development and clinical research services to the pharmaceutical, biotechnology and medical device industries. The company partners with clients at all stages of the product life cycle, offering expertise in protocol design, trial execution and regulatory compliance across a broad range of therapeutic areas.

Icon’s service portfolio encompasses clinical trial management, data management and biostatistics, medical imaging, pharmacovigilance and safety monitoring, laboratory sciences and specialized analytical solutions.

Further Reading

• Five stocks we like better than Icon
• These Stocks Could Win as Wall Street Looks Beyond AI Software
• D.R. Horton Is Defying the Housing Gloom
• Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
• Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential

Want to see what other hedge funds are holding ICLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR – Free Report).

Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.